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Severe acute malnutrition (SAM) is a major cause of mortality in children under 5 years and
is associated with hepatic steatosis. Bile acids are synthesized in the liver and participate in
dietary fat digestion, regulation of energy expenditure, and immune responses. The aim of
this work was to investigate whether SAM is associated with clinically relevant changes in
bile acid homeostasis.
Design
An initial discovery cohort with 5 healthy controls and 22 SAM-patients was used to identify
altered bile acid homeostasis. A follow up cohort of 40 SAM-patients were then studied on
admission and 3 days after clinical stabilization to assess recovery in bile acid metabolism.
Recruited children were 6–60 months old and admitted for SAM in Malawi. Clinical charac-
teristics, feces and blood were collected on admission and prior to discharge. Bile acids, 7α-
hydroxy-4-cholesten-3-one (C4) and FGF-19 were quantified.
Results
On admission, total serum bile acids were higher in children with SAM than in healthy con-
trols and glycine-conjugates accounted for most of this accumulation with median and inter-
quartile range (IQR) of 24.6 μmol/L [8.6–47.7] compared to 1.9 μmol/L [1.7–3.3] (p = 0.01)
in controls. Total serum bile acid concentrations did not decrease prior to discharge. On
admission, fecal conjugated bile acids were lower and secondary bile acids higher at admis-
sion compared to pre- discharge, suggesting increased bacterial conversion. FGF19 (Fibro-
blast growth factor 19), a marker of intestinal bile acid signaling, was higher on admission
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and was associated with decreased C4 concentrations as a marker of bile acid synthesis.
Upon recovery, fecal calprotectin, a marker of intestinal inflammation, was lower.
Conclusion
SAM is associated with increased serum bile acid levels despite reduced synthesis rates. In
SAM, there tends to be increased deconjugation of bile acids and conversion from primary
to secondary bile acids, which may contribute to the development of liver disease.
Introduction
Background on severe acute malnutrition
Severe acute malnutrition (SAM) is a major cause of death in children under the age of five
years [1]. The pathophysiology of SAM is poorly understood but has been associated with liver
disease, most commonly hepatic steatosis. In addition, SAM is associated with significant intes-
tinal disturbances, such as mucosal atrophy [2] and impaired intestinal epithelial barrier func-
tion [3, 4]. Also, lipid [3, 5] and carbohydrate [6] maldigestion and malabsorption are
common in SAM. Two studies recently described profound SAM-associated changes in the
intestinal microbiota [7, 8]. Considering that children hospitalized with complicated SAM
have a mortality rate of up to 30%, it is crucial to better understand the pathophysiological
underpinnings of SAM [9–11].
The impaired hepatic and intestinal functions together with the altered microbiota seen in
SAM patients could be related to changes in bile acid homeostasis. Bile acids are synthesized in
hepatocytes and the rate-limiting step for their synthesis is controlled by Farnesoid X Receptor
(FXR). FXR is a nuclear receptor mostly expressed in the liver and intestines that is activated
by BAs which can be modulated by intestinal microbiota [12]. In the intestine, FXR induces
Fibroblast growth factor-19 (FGF19) transcription when BA levels in the ileum are elevated
[13]. FGF19 then enters circulation and negatively regulates bile acid synthesis in the liver by
inhibiting the rate-limiting enzyme cholesterol 7α-hydroxylase (CYP7A1) through Fibroblast
growth factor receptor-4mediated signaling [14]. The intermediate 7α-Hydroxy-4-cholesten-
3-one (C4) is produced while synthesizing bile acids from 7α-hydroxycholesterol, which is itself
produced from cholesterol by hepatic CYP7A1 [15]. C4 is a measure of bile acid synthesis rate.
Following BA synthesis, primary bile acids chenodeoxycholic acid (CDCA) and cholic acid
(CA) are conjugated with glycine or taurine and released in the small intestine to facilitate lipid
emulsification, digestion and absorption. There, they are deconjugated and modified into sec-
ondary bile acids by intestinal microbiota leading to deoxycholic acid (DCA, from CA) and
lithocholic acid (LCA, from CDCA) synthesis [16]. Bile acids are intrinsically toxic to cells
mainly due to their inherent detergent and membrane disruptive properties, which can contrib-
ute to hepatotoxicity, impaired epithelial barrier function and increased bacterial translocation
[17, 18]. Bile acids have both hydrophobic and hydrophilic properties with hydrophobic strength
ordered as LCA>DCA>CDCA>CA [19]. Hydrophobic bile acids (such as LCA) can contribute
to intestinal inflammation [19]. Considering that SAM is associated with dysbiosis and that
intestinal microbiota regulate bile acid synthesis, deconjugation and metabolism, it is important
to understand the role of bile acids in the development of SAM-related complications.
There is paucity of data on the topic of bile acid homeostasis in SAM [20, 21]. Understand-
ing their role would provide important insight into the pathogenesis of malnutrition and its
Bile Acid Homeostasis in Malnutrition
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complications but more importantly may suggest future therapeutic targets. We therefore
aimed to address the following questions: 1. Is SAM associated with changes in the homeostasis
of bile acids? 2. If so, does nutritional rehabilitation restore bile acid homeostasis in patients
with SAM? 3. Do changes in bile acid metabolism relate to markers of intestinal or hepatic
inflammation?
Subjects and Methods
Patient recruitment and study design
Recruited children were 6 months to 5 years of age and hospitalized for SAM at Queen Elisa-
beth Central Hospital in Blantyre, Malawi. The discovery cohort was composed of 22 SAM-
patients and 5 healthy controls recruited for a study evaluating glucose homeostasis. The follow
up cohort was composed of 40 SAM-patients recruited for a prospective study aimed at investi-
gating the outcome of three WHO recommended standard rehabilitation diets (ISRCTN
13916953). Exclusion criteria were suspected tuberculosis, confirmed malaria or lack of suffi-
cient serum for analyses. Patients with kwashiorkor, marasmus or HIV were included. Healthy
controls were recruited at hospital discharge having recovered from minor orthopedic or sus-
pected viral respiratory problems. Written consent was obtained from care givers using paper
consent forms in accordance with the protocol approved by the College of Medicine Research
Ethics Committee, Malawi, and the Research Ethics Board (REB number 1000048167) at the
Hospital for Sick Children, Toronto, Canada.
Inpatient treatment
As per protocol, all hospitalized patients received broad-spectrum antibiotics on admission
and in addition, children with HIV continued with their outpatient treatment of oral cotrimox-
azole prophylaxis for pneumocystis jiroveci pneumonia. Nutritional management of patients
was initially based on the standard WHO protocol, which recommends a low-energy (75–100
kcal energy/kg/day), low-protein (F75; 1.2g protein/kg/day) liquid diet until improvement of
appetite and, for children with kwashiorkor, loss of edema [22]. Subsequently, calorie intake
was increased and children were either given Ready-to-use therapeutic food (RUTF) supple-
mented with F75 if required, or a more calorie dense formula, i.e., F100.
Clinical data and specimen collection
Baseline clinical data were recorded for weight, height, MUAC and presence and degree of
edema and weight was then monitored daily. Unfasted blood samples were collected within 24
hours of admission for the discovery cohort. We obtained additional samples in the follow up
cohort where both unfasted blood and stool were collected upon admission and 3 days after
clinical stabilization just prior to discharge. Serum aliquots and fecal samples were frozen and
stored at -80°C until analysis.
Serum and fecal bile acid analysis
Serum bile acid concentrations of the discovery cohort were determined by high-performance
liquid chromatography (HPLC) negative ion electrospray tandem mass spectrometry as
described previously [23]. Those of the follow up cohort were measured by liquid chromatog-
raphy–mass spectrometry (LC-MS) using the Biocrates1 Life Sciences Bile Acids Kit (Bio-
crates, Innsbruck, Austria) as per manufacturer’s instructions using an Agilent UHPLC 1290
LC system coupled to an ABSciex QTRAP 5500 in negative ESI MRMmode. The same kit was
used to analyze fecal bile acids. Samples were lyophilized, reconstituted with 75% ethanol and
Bile Acid Homeostasis in Malnutrition
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homogenized then vortexed for 5 minutes and centrifuged at 20,000 g for 10 minutes. The
resulting supernatant was used for bile acids measurement.
Determination of hepatic bile acid synthesis 7α-hydroxy-4-cholesten-
3-one (C4)
Serum C4 measurement was performed by LC-MS-MS. C4 was extracted using a salting-out
method as previously described [24, 25]. Serum samples were prepared alongside of authentic
C4 standards. Briefly, 100 μL of serum was diluted with 200 μL of distilled water, to which 5 ng
of d7-C4 (used as internal standard) and 500 μL of acetonitrile were added. Then, 100 mg of
ammonium sulfate was added, tubes vortexed for 1 minute and centrifuged at 2,000 g at 4°C
for 5 minutes. The supernatant acetonitrile phase was collected and dried under nitrogen at
35°C. The residues were reconstituted with 200 μL methanol, vortexed for 1 minute, incubated
for 10 minutes and centrifuged at 20,000 g for 5 minutes. Clear supernatants were transferred
to 250 μL inserts for LC-MS-MS analysis. The LC-MS-MS system consisted of an Agilent
UHPLC 1290 LC system coupled to an ABSciex QTRAP 5500 in positive ESI MRMmode.
Chromatographic separation was performed using a XB-C18 kinetex column (50 x 3.0 mm,
2.6 μm; Phenomenex) operated at a flow rate of 800 μL/minute and eluted isocratically with a
mobile phase consisting of acetonitrile/water (98/2, v/v) with 0.1% trifluoroacetic acid. Quanti-
tation of C4 was achieved by comparing the deuterium-to-protium ratio of the samples with a
standard using the Analyst 1.6 software.
Determination of fibroblast growth factor (FGF) 19 and calprotectin
Serum FGF-19 levels were determined using sandwich enzyme-linked immunosorbent assay
(R&D Systems, Minneapolis, MN, USA) as per manufacturer’s instructions. Samples (100 μl)
were diluted (1:2) using the Calibrator Diluent RD5P (1X) supplied with the kit. Fecal calpro-
tectin was measured by standard enzyme-linked immunoabsorbent assay (Bühlmann Labora-
tories, Schönenbuch, Switzerland). Alanine aminotransferase (ALT) concentrations were
determined using standard laboratory analyses.
Statistical analysis
Data were expressed as median (IQR). Mann-Whitney test was used to compare controls and
SAM-patients of the discovery cohort whereas Wilcoxon signed rank test for paired samples
was used to compare admission and prior to discharge in the follow up cohort. Differences in
calprotectin at admission and pre-discharge were tested for significance with mixed effects
models with patients set as random factor to account for missing data and within patient
repeated measures. Spearman’s correlations were used to determine relationships between
non-parametric data. The significance threshold was set at p-value<0.05 for all statistical tests.
Analyses were conducted with SPSS 22.0 software (IBM Corporation) and R statistical software
(Version 3.2.2). Plots were generated using ggplot2 [26].
Results
The clinical characteristics of all study participants (n = 75) are detailed in Table 1. Children
were on average 24.8 ± 11.7 months old. A substantial proportion of the malnourished children
(44%) were HIV positive and more than 60% presented with edema. Electrolyte imbalance was
apparent with approximately 20% of patients showing either hypo- or hypernatremia. Levels of
ALT, a marker of liver injury, were increased in SAM-patients with a median (IQR) of 46 [27–
64] IU/I compared to14 [9–17] IU/I in healthy controls (p<0.001).
Bile Acid Homeostasis in Malnutrition
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Our discovery cohort showed that bile acid homeostasis is altered in SAM-patients com-
pared to controls as detailed in Fig 1A. Serum bile acid profiles of malnourished children
showed higher levels of total bile acids and this accumulation was mainly driven by conjugated
bile acids. The glycine-conjugates were markedly elevated with a median (IQR) of 24.6 μmol/l
[8.6–47.7] compared to 1.9 μmol/l [1.7–3.3] in controls (p = 0.01). Eleven children with SAM
had detectable levels of C27 bile acids, i.e., trihydroxycholestanoic acid (THCA) and dihydrox-
ycholestanoic acid (DHCA), but the total concentration was not significantly different from
controls (S1 Table). Finally, there was a significant correlation between ALT and the concentra-
tions of serum bile acids (ρ = 0.52, p<0.001) (Fig 1B). Even though 40% of our study cohort is
HIV sero-positive, we did not find any significant effect of HIV on bile acids.
With the follow up cohort, we could analyze both serum and fecal samples on admission
and prior to discharge in SAM-patients (Tables 2 and 3 and S2 and S3 Tables). Total serum
concentration of bile acids did not differ between admission and pre-discharge with medians
(IQR) of 18.4 μmol/l [5.1–33.2] and 16.6 μmol/l [8.0–33.8], respectively (Table 2). Yet, the ratio
of conjugated to unconjugated bile acids increased significantly between admission and prior
to discharge with median (IQR) of 43.9 μmol/l [21.8–120] compared to 116.1 μmol/l [55.3–
457] (p<0.01). In fecal samples, conjugated bile acids were markedly lower 21.5 pmol/mg
feces [6.7–119] to 148 pmol/mg feces [20.2–893] on admission compared to clinical recovery,
i.e., prior to discharge. However, secondary unconjugated bile acids were significantly higher
on admission going from 49.3 pmol/mg feces [3.2–1215] to 1.8 pmol/mg feces [0.6–8.9]
(p<0.001) (Table 3). There were no consistent differences between bile acid profiles in children
with kwashiorkor compared to marasmus.
Markers of intestinal bile acid signaling (FGF19), and hepatic bile acid synthesis (C4) were
altered between admission and pre-discharge. Serum FGF19 concentrations decreased from
48.0 [21.6–77.8] pg/ml to 16.9 [0–48.5] pg/ml (p = 0.007) after stabilization indicating higher
intestinal bile acid signaling at admission (Fig 2A) and this was associated with lower C4 con-
centrations on admission compared to discharge, i.e., 4.2 ng/ml [1.8–7.8] and 12.1 ng/ml [3.5–
Table 1. Characteristics of all patients at admission.
Control Malnourished
(n = 5) (n = 70)
Age (month) 26 ±10.3 23.7 ±1.4
Female, n (%) 1 (20) 41 (58.6)
Weight (kg) 10.1 ± 1.9 7.4 ±0.3
MUAC (cm) 13.3 ± 0.6 11.3 ± 0.2
Length (cm) 78.9 ± 6.5 75.9 ± 1.1
Weight- for-height, Z score -0.2 ± 0.8 -3.1 ± 1.8
Kwashiorkor, n (%) 0 43 (61.4)
HIV positive, n (%) 0 31 (44.3)
Diarrhea within ﬁrst 24 hr, n (%) - 9 (19.6)
Hyponatremia,1 n (%) 0 10 (12.8)
Hypernatremia,2 n (%) 0 7 (9.0)
Duration of stay (days) - 12 ± 4.8
Alanine aminotransaminase (IU/I) ϯ 14.0 (8.5–16.5) 45.5 (26.5–63.8)
Values are presented as mean ±SD, n (%) or median with interquartile range (IQR) as indicated by ϯ.
1 Hyponatremia deﬁned as a plasma sodium concentration < 130 mmol/L
2 Hypernatremia deﬁned as a plasma sodium concentration > 145 mmol/L
doi:10.1371/journal.pone.0155143.t001
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Fig 1. A) Bile acids accumulate in serum of SAM patients compared to controls in discovery cohort. Bar graphs represent mean and standard deviation
(SD). Peaks for conjugated and unconjugated CDCA and DCA were indistinguishable and therefore presented as combined values (CDCA/DCA).
Significant differences between healthy controls and patients with severe acute malnutrition (SAM) are indicated with stars; * p-value<0.05, ** p-
value < 0.01 (Mann-Whitney test). B) Correlation between serum alanine aminotransaminase (ALT) and total bile acids concentrations in serum from the
children with severe acute malnutrition of the follow up cohort. Values presented on log-scale. (Spearman correlation = 0.52, p<0.001).
doi:10.1371/journal.pone.0155143.g001
Bile Acid Homeostasis in Malnutrition
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29.3] (p<0.001) (Fig 2B). Levels of FGF19 negatively correlated with those of C4 both at admis-
sion (ρ = -0.49, p-value<0.002) and prior to discharge (ρ = -0.67, p-value<0.001) (Fig 2C and
2D). Fecal calprotectin, a marker of intestinal inflammation, was lower in children that were to
be discharged (Fig 2E). However, there was no correlation between fecal bile acids, and the
presence of diarrhea, or the fecal calprotectin levels.
Discussion
Children with complicated SAM suffer from high inpatient and post-discharge mortality rates
[27]. SAM has been associated with abnormal hepatic function [28], enteropathy [29] and
intestinal dysbiosis [8]. As the liver, intestine and intestinal microbiota play a central role in
regulating bile acid homeostasis, we hypothesized that these processes would be altered in chil-
dren with SAM. Indeed, we showed that SAM is associated with increased serum bile acid lev-
els, which remained elevated following standard nutritional intervention suggesting that
Table 2. Serum bile acid concentrations in severely malnourished children at admission and prior to discharge in the follow up cohort.
Admission Pre-discharge
Serum bile acids (mmol/L) (n = 40) (n = 40) p-value
Conjugated 18.2 (5.0–32.2) 16.7 (8.1–33.3) n.s
Glycine-conjugated 16.0 (4.7–26.1) 14.8 (7.1–31.9) n.s
Taurine-conjugated 1.2 (0.5–3.2) 1.3 (0.6–2.7) n.s
G/T ratio 9.4 (7.0–20.7) 12.2 (7.4–17.1) n.s
Unconjugated 0.3 (0.1–0.6) 0.17 (0.05–0.35) n.s
Primary bile acid (CA+CDCA) 0.3 (0.1–0.5) 0.1 (0.05–0.3) n.s
Secondary bile acid (LCA+DCA) 0.01 (0.0–0.1) 0 (0.0–0.0) n.s
Secondary/Primary Ratio 0.05 (0.0–0.3) 0 (0.0–0.0) <0.01
Conjugated/Unconjugated ratio 43.9 (21.8–120) 116.1 (55.3–457) <0.01
Total bile acid 18.4 (6.0–33.2) 17.0 (9.1–33.7) n.s
Values expressed as median and interquartile range. Signiﬁcant differences between admission and prior to discharge in patients with severe acute
malnutrition (SAM) are indicated in bold, p<0.05 (Wilcoxon-signed Rank test). p-value >0.1 indicated as n.s. (not signiﬁcant).
doi:10.1371/journal.pone.0155143.t002
Table 3. Fecal bile acids concentrations during admission and at Pre-discharge.
Admission Pre-discharge
Fecal bile acids (pmol/mg) (n = 36) (n = 37) p-value
Conjugated BA 21.5 (6.7–119) 148 (20.2–893) <0.01
Unconjugated BA 2761 (1792–5790) 2328 (1156–4565) n.s
Primary bile acid (CA+CDCA) 1894 (563–5536) 2306 (978–4347) n.s
Secondary bile acid (LCA+DCA) 49.3 (3.2–1215) 1.8 (0.6–8.9) <0.001
Secondary/Primary Ratios 0.04 (0.0–1.2) 0.0 (0.0–0.01) n.s
LCA/CDCA ratio 0.01 (0.0–1.2) 0.0 (0.0–0.001) n.s
DCA/CA ratio 0.07 (0.0–1.2) 0.001 (0.0–0.01) n.s
LCA 13.8 (0.9–387) 0.2 (0.01–1.2) <0.001
DCA 23.1 (1.9–717) 1.4 (0.6–7.0) <0.01
Conjugated/Unconjugated ratio 0.01 (0.0–0.08) 0.05 (0.01–0.4) n.s
Total bile acid 2849 (1949–6214) 3425 (1978–5487) n.s
Values expressed as median and interquartile range. Signiﬁcant differences between admission and Pre-discharge in patients with severe acute
malnutrition (SAM) are indicated in bold, p<0.05 (Wilcoxon-signed Rank test). p-value > 0.1 indicated as n.s. (not signiﬁcant)
doi:10.1371/journal.pone.0155143.t003
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Fig 2. Differences in serum levels of A) FGF19 and B) C4 in children from the follow up cohort at admission and pre-
discharge. FGF19 negatively correlates with serum concentration of C4 at C) admission and D) prior to discharge. E) Fecal
calprotectin is decreased in children to be discharged. Boxplots represent 25th and 75th quartiles, box-midline indicates
Bile Acid Homeostasis in Malnutrition
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normal bile acid homeostasis may not be attained in children deemed ready for discharge.
They however show an increase in conjugated fecal bile acids, a decrease in serum FGF19 and
increase in C4 levels.
The higher levels of total serum bile acids seen in children with SAM compared to controls
could, in theory, reflect reduced hepatic bile acid uptake and hepatic biliary secretion, or
increased re-absorption of bile acids at the level of the intestine. Two studies analyzing duode-
nal contents of children with SAM showed that SAM is associated with lower biliary concentra-
tion of particularly conjugated bile acids [20, 21]. Hepatic basolateral uptake of bile acids is
mediated by the sodium/taurocholate co-transporting polypeptide (NTCP) and, to a lesser
degree, solute carrier organic anion transporters (OATP’s). Expression of NTCP and OATP’s
have been found to be reduced during hepatic inflammation or cholestasis as a protective
mechanism [30] and might form an explanation for reduced duodenal bile acid concentrations
in children with SAM. In addition, SAM is associated with bile acid malabsorption [31]. Our
findings, along with these previously published studies suggest that increased serum bile acid
levels most likely relate to reduced hepatic bile acid uptake and biliary secretion.
The lower levels of fecal conjugated bile acids that we found in children with SAM com-
pared to pre-discharge was also demonstrated in a recent pre-clinical model of moderate mal-
nutrition [4]. In conjunction with high levels of secondary bile acids in malnourished children
on admission, these data suggest that potentially, dysbiosis associated with SAM [8] leads to
increased deconjugation of bile acids. The latter renders them less bioavailable and, hence,
more likely to pass into the colon where they can be converted from primary to secondary bile
acids, through the action of certain bacteria. This has previously been attributed to bacterial
overgrowth into the small intestine [32]. Finally, all children are treated with broad spectrum
antibiotics which alters the microbiome and likely reduces the bacterial content in the small
intestine. This could also lead to selective pressure against Clostridium leptum which can mod-
ify bile acids through 7α-dehydroxylation and de-conjugation inducing primary to secondary
conversion [33, 34].
Bile acid synthesis via the classical pathway was reduced in children with SAM as indicated
by lower C4 levels compared to pre-discharge. The nuclear bile acid receptor, FXR, highly
expressed in the liver and intestine, regulates bile acid synthesis. The increased level of FGF19
during admission compared to pre-discharge could be related to an increased ileal presence of
hydrophobic bile acids, which are stronger ligands for FXR [35]. Circulating FGF19 binds to
FGFR4 in hepatocytes to negatively regulate bile acid synthesis in the liver by inhibiting the
rate-limiting enzyme CYP7A1 [14]. Lower C4 levels in children with SAM were associated
with higher FGF19 indicating increased inhibition of bile acid synthesis, which is an appropri-
ate response considering the increased serum bile acid levels.
SAM has been associated with liver steatosis and inflammation [28]. In addition, serum
ALT has been found to be especially increased in kwashiorkor thus indicating hepatic injury
[36]. Elevated ALT is also found in hepatic steatosis or NAFLD-like phenotype [37]. It is
known that hydrophobic bile acids can exert cytotoxic effects through the production of reac-
tive oxygen/nitrogen species [38]. Their hepatotoxic impact causes stellate cells to proliferate
and initiate apoptotic pathways [39, 40]. Bile acid induced hepatotoxicity has been implicated
in the pathogenesis of liver injury in cholestatic liver diseases [41] and non-alcoholic fatty liver
median and whiskers define top and bottom values within 1.5 times the inter-quartile range (IQR). Wilcoxon Signed Rank
test was used to compare admission and pre-discharge for FGF19 and C4. Mixed effects models were used to test
differences in calprotectin to account for missing values. Spearman test was used for correlation. Stars indicate; * p-
value < 0.05, ** p-value < 0.01.
doi:10.1371/journal.pone.0155143.g002
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disease (NAFLD) [42]. Since we have found both a correlation between ALT and total bile
acids and that malnutrition shifts the bile acid profiles towards a predominance of secondary
bile acids, it would be important to determine whether these homeostatic changes play a role in
the development of liver disease in SAM.
Similarly to the liver, bile acids can also cause intestinal injury. DCA and CDCA can pro-
mote apoptosis of colonocytes, with CDCA being more toxic [43]. Also, DCA and CDCA may
enhance mucosal permeability and bacterial infiltration in enterocytes, which can further pro-
mote intestinal inflammation [17, 18]. DCA and CDCA have also been shown to increase
intestinal permeability through epidermal growth factor receptor autophosphorylation, occlu-
din dephosphorylation and re-arrangement of tight junctions [18]. We found that children
close to being discharged had lower fecal calprotectin indicating that intestinal inflammation
may be at least in part resolved. Our study, however, did not find a correlation between calpro-
tectin, a marker of intestinal inflammation, and bile acids. This would need to be investigated
further with histological data.
This study has several limitations. First, recruiting age-matched controls proved to be highly
challenging in Malawi as caregivers were reluctant to provide multiple blood samples. It is very
difficult to obtain consent from caregivers to take blood or stool from their children, especially
if healthy due in part to cultural beliefs. We first aimed to determine whether bile acid concen-
trations are elevated in ill malnourished children. SAM changes liver metabolic function thus it
is expected to also impact bile acid homeostasis. Unfortunately, we could not measure bilirubin
levels since only small aliquots were available and stored samples had been exposed to variable
amounts of light which would have affected measurements. We also did not have stool samples
from healthy children to study the differences in bile acid elimination between healthy and
malnourished children. In addition, the role of broad spectrum antibiotics was not determined
as all children received protocolized antibiotics as per WHO treatment guidelines [44]. Mortal-
ity rate is up to 30% and infections are common, which explains the wide use of antibiotics in
all children for at least 5 days. As bacteria play an important role in intestinal bile acid homeo-
stasis, antibiotic treatment likely impact the results. These limitations and the fact that data
was collected from two separate cohorts limits the ability to draw strong overarching conclu-
sions. Despite these limitations, our results are still clinically informative given the extreme
scarcity of data on bile acid homeostasis in severe acute malnutrition. However, we look for-
ward to validating these results in future studies.
In conclusion, we provide evidence that bile acid homeostasis in children with SAM is sig-
nificantly disturbed. These findings could have potential clinical implications relating to nutri-
tional rehabilitation and interventions aimed at restoring intestinal and hepatic function in this
highly vulnerable patient population.
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